VitaPhyte Redness Reliever Lubricant Eye Drops

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
VitaPhyte Redness Reliever Lubricant Eye Drops
Generic name
REDNESS RELIEVER LUBRICANT EYE DROPS
Manufacturer
Guangzhou Liyan Cosmetics Technology Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
53d4e9b0-c9a0-797a-e063-6294a90ad0cf
SPL ID
53d4e9b0-c9a1-797a-e063-6294a90ad0cf
Version
1
Effective date
2026-06-04
Source export date
2026-10-27
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:24:57
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Ask a doctor before use if you have • glaucoma or other serious eye conditions • persistent eye redness or pain When using this product • do not touch the tip of the container to any surface • remove contact lenses before application • temporary blurred vision or mild stinging may occur • overuse may increase eye redness • discontinue use if solution changes color or becomes cloudy • replace cap tightly after each use Stop use and ask a doctor if • eye pain or irritation worsens • redness persists for more than 72 hours • vision changes occur • symptoms do not improve Keep out of reach of children. If swallowed, seek medical assistance or contact a Poison Control Center immediately. If pregnant or breast-feeding, consult a healthcare professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.